0000899243-20-019024.txt : 20200713 0000899243-20-019024.hdr.sgml : 20200713 20200713214013 ACCESSION NUMBER: 0000899243-20-019024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200709 FILED AS OF DATE: 20200713 DATE AS OF CHANGE: 20200713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HASTINGS PAUL J CENTRAL INDEX KEY: 0001309702 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 201026207 MAIL ADDRESS: STREET 1: 61 HARTFORD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-215-0385 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-09 0 0001787400 Nkarta, Inc. NKTX 0001309702 HASTINGS PAUL J C/O NKARTA, INC. 6000 SHORELINE COURT, SUITE 102 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 See Remarks Stock Option (right to buy) 18.00 2020-07-09 4 A 0 202400 0.00 A 2030-07-08 Common Stock 202400 202400 D This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Chief Executive Officer and Director /s/ Matthew Plunkett, Attorney-in-Fact for Paul J. Hastings 2020-07-10